Press Releases :: Acurx Pharmaceuticals, Inc. (ACXP)

Acurx Pharmaceuticals to Discuss Second Quarter 2023 Financial Results and Provide Business Update

Jul 24, 2023

Acurx Pharmaceuticals to Present at the Emerging Growth Conference on July 12, 2023

Jun 20, 2023

Acurx Pharmaceuticals to Participate in the Maxim Group LLC Virtual Healthcare Conference on Tuesday, June 20, 2023 to Thursday, June 22, 2023 at 9 am ET

Jun 15, 2023

Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering

May 16, 2023

Acurx Pharmaceuticals, Inc. Reports First Quarter 2023 Results and Provides Business Update

May 12, 2023

Acurx Pharmaceuticals to Discuss First Quarter 2023 Financial Results and Provide Business Update

May 5, 2023

Acurx Announces Ibezapolstat Scientific Poster and Update on its Pol IIIC Pipeline Presented at ECCMID 2023 Scientific Conference

Apr 19, 2023

FDA Accepts Interim Analysis Plan for Ongoing Phase 2b Ibezapolstat Clinical Trial and Acurx Announces Presentations at ECCMID 2023 Scientific Conference

Apr 11, 2023

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

Mar 16, 2023

Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update

Mar 6, 2023